Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Neurensin-1 Inhibitors

Neurensin-1 inhibitors are a class of compounds that specifically target and inhibit the activity of Neurensin-1, a protein that is implicated in various cellular functions within the nervous system. The protein itself is a member of the small, soluble, intracellular lipid-binding protein (iLBPs) family, believed to be involved in the intracellular transport of small hydrophobic molecules, including signaling lipids which play crucial roles in maintaining neuronal integrity and function. Inhibitors of Neurensin-1 work by binding to the protein in a manner that obstructs its normal function, potentially altering the intracellular distribution and concentrations of its lipid cargo. The exact binding sites and inhibition mechanisms can be diverse, depending on the molecular structure of the inhibitor and its physicochemical properties, such as shape, charge, and hydrophobicity.

To elucidate the specifics of how Neurensin-1 inhibitors interact with their target, researchers employ various biochemical and biophysical techniques. For instance, assays that measure the binding affinity and kinetics of these inhibitors can reveal how tightly and quickly an inhibitor associates with and dissociates from Neurensin-1. Additionally, structural studies using methods like X-ray crystallography or cryo-electron microscopy can provide a detailed three-dimensional picture of the inhibitor-bound protein, shedding light on the precise molecular interactions responsible for inhibition.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wiskostatin

253449-04-6sc-204399
sc-204399A
sc-204399B
sc-204399C
1 mg
5 mg
25 mg
50 mg
$49.00
$124.00
$441.00
$828.00
4
(1)

Inhibitor of N-WASP, affecting actin polymerization, potentially altering the cellular environment where Neurensin-1 operates.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, may affect Neurensin-1 by altering downstream signaling pathways involved in neuronal survival and function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor, can influence MAPK/ERK pathway, potentially modifying the cellular context and affecting Neurensin-1 activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor, can modify the stress response pathways that might intersect with Neurensin-1's role in neurons.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, can alter the JNK signaling pathway, which may intersect with Neurensin-1's functioning in neurons.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

CaMKII inhibitor, can influence calcium signaling pathways, potentially affecting the cellular processes involving Neurensin-1.

Chelerythrine chloride

3895-92-9sc-3547
sc-3547A
5 mg
25 mg
$90.00
$317.00
17
(1)

PKC inhibitor, can change protein kinase C activity, possibly influencing signaling pathways where Neurensin-1 is active.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor that may modulate cytoskeletal dynamics, potentially affecting Neurensin-1's role in neurons.

BAPTA, Free Acid

85233-19-8sc-201508
sc-201508A
100 mg
500 mg
$68.00
$267.00
10
(1)

Calcium chelator, can change intracellular calcium levels, potentially influencing Neurensin-1's activity or localization.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

SERCA pump inhibitor, can elevate intracellular calcium levels, potentially influencing Neurensin-1's role in neurons.